ENUVIO
eNUVIO designs and produces new cutting-edge tools for the life science research, drug discovery, and safety assessment markets. Our main focus is on developing disruptive technologies that help to facilitate and accelerate life science research. eNUVIO’s lab-on-a-chip technologies are specifically designed with the research scientist in mind, a concept that is reflected in all our products.
ENUVIO
Industry:
Biotechnology Health Care Life Science
Founded:
2016-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.enuvio.com
Total Employee:
1+
Status:
Active
Contact:
(514) 254 5583
Email Addresses:
[email protected]
Total Funding:
50 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
RNAimmune
RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
Government of Canada
Government of Canada investment in Grant - eNUVIO
Front Row Ventures
Front Row Ventures investment in Venture Round - eNUVIO
Centech
Centech investment in Non Equity Assistance - eNUVIO
